ArticleEndocrine connections2024

TGFBR3 inhibits progression of papillary thyroid cancer by inhibiting the PI3K/AKT pathway and EMT.

Hanrong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.